Fibre type analysis is an important procedure in the study of normal and diseased skeletal muscle. The discrimination of fibre types is routinely achieved by the use of enzyme histochemical techniques, and in particular that for adenosine triphosphatase (ATPase) after preincubation at various pH values.' Fibre type differentiation has also been shown immunocytochemically by the use of a monoclonal antibody that recognises type II muscle fibre2 and by the use of polyclonal antisera raised against various muscle proteins. 3 We report here a monoclonal antibody, F7, that reacts selectively with human type I skeletal muscle fibres. This antibody may be used on frozen sections and on formalin fixed wax embedded sections.
Material and methods

MONOCLONAL ANTIBODIES
Monoclonal antibodies were produced, as previously described.6 Monoclonal antibody, F7, was produced from a fusion using the cells from the spleen of a BALB/c mouse that had been immunised with a Triton-X-100 insoluble fraction from human brain stem; these were fused with the cells of the murine myeloma cell line P3 X63.Ag. Dodson, Garson, Burke, Anderton peroxidase technique. Sections were dewaxed in xylene and taken to TBS. They were incubated with normal rabbit serum (Dakopatts) for 30 minutes, followed by incubation with F7, BE4, or P3 X.63.Ag.8.653 tissue culture supernatant for 60 minutes. The remainder of the protocol was the same as that previously described for the cryostat sections.
Results
The enzyme histochemical method for ATPase at pH 9.4 differentiated the type I muscle fibres, which were negative to lightly stained from the darkly stained type II fibres (fig la) .
Immunocytochemical staining of cryostat sections (fig ib) and of paraffin sections (fig ic) using the F7 antibody produced concordant results, showing that a subset of fibres was selectively stained. By comparison with the enzyme histochemical preparation it was possible to establish that this subset corresponded to the type I muscle fibres.
The BE4 antibody produced staining that was confined to the nuclei present in the cryostat and paraffin sections. BE4 showed no staining of any muscle fibres.
Sections incubated with P3 X63.Ag.8.653 supernatant produced no staining.
Discussion
We have shown that the antibody F7 selectively recognises type I muscle fibres in human skeletal muscle and that it may be used to carry out fibre type analysis on routinely fixed and processed specimens. Because the enzyme histochemical methods, which are currently used for fibre typing, do not work on processed material, it has been impossible in the past to carry out retrospective studies on wax embedded material. Similarly, several of the antibodies, which have been previously described as being fibre type specific, have not been shown to work on routinely processed material. F7 now provides an opportunity for retrospective study. It also provides an alternative to the production of cryostat sections in prospective work, and this may prove especially useful when dealing with material with a known infectious hazard.
F7 has also been used to stain necropsy material and has been found to give good results (results not shown).
In an attempt to characterise further the antigen recognised by F7 it has been used in immunoblotting techniques (results not shown). It gives multiple bands with homogenates of whole skeletal muscle, indicating that it recognises an epitope shared by multiple polypeptides. We have thus far been unable to identify a single molecular species which is present only in type I fibres; nevertheless, operationally, the F7 antibody is a useful diagnostic tool.
